Scilex Holding Company Has Appealed Lower Court Decision to the U.S. Court of Appeals for the Federal Circuit in Washington, DC and Will Continue to Vigorously Pursue its Infringement Action Against Aveva
Portfolio Pulse from
Scilex Holding Company has appealed a lower court decision to the U.S. Court of Appeals for the Federal Circuit regarding a patent infringement lawsuit against Aveva Drug Delivery Systems. In July 2024, a District Court found that Aveva's proposed product did not infringe Scilex's ZTlido patents. Scilex remains committed to vigorously pursuing the infringement action and believes strongly in the strength of its intellectual property.
March 27, 2025 | 12:45 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
The ongoing patent infringement lawsuit could impact Scilex's intellectual property strategy and potential future revenue from ZTlido product line.
The appeal represents a critical legal strategy to protect Scilex's intellectual property rights for the ZTlido product. While the immediate financial impact is neutral, a successful appeal could preserve future revenue streams and market exclusivity.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100